Interline Therapeutics

About:

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

Website: https://www.interlinetx.com

Twitter/X: InterlineTx

Top Investors: Foresite Capital, ARCH Venture Partners

Description:

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities. It uses genomics, proteomics, structural biology, and computational chemistry to map and modulate protein communities. Interline leverages recent advancements in these technologies, as well as collaborations with leading academic groups, to develop a precision medicine platform focused on three essential areas, genomics, communities, and modulators. The South San Francisco, California-located company was founded by Zach Sweeney in 2020.

Total Funding Amount:

$92M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2020-01-01

Founders:

Zach Sweeney

Number of Employees:

11-50

Last Funding Date:

2021-05-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai